medline.ch Gastroenterologie Pankreas Neoplasie

	A decade of progress: a before and after study on improved survival in pancreatic cancer through evolving multimodal therapy. Int J Surg Liao TK, Wang CJ, Lu WH, Su PJ, Huang CJ, Su YY, Yen CC, Liu IT, Yen CJ, Chao YJ, Shan YS. PMID: 42682329 [PubMed]
	Early versus late supplemental parenteral nutrition in gastrointestinal cancer patients undergoing major abdominal surgery: 5-year outcomes from a randomized clinical trial. Int J Surg Gao X, Zhang Y, Xiao Y, Gao T, Jin G, Wang K, Zhou Y, Chi Q, Yang H, Li M, Yu J, Qin H, Tang Y, Wu X, Li G, Zhang L, Wang X. PMID: 42682285 [PubMed]
	Ezetimibe Treatment Is Associated with Lower Risk of Incident Cancer: A Nationwide Population-Based Cohort Study. Endocrinol Metab (Seoul) Cho Y, Park HS, Park MA, Park S, Seo DH, Ahn SH, Hong S, Kim SH. PMID: 42681843 [PubMed - as supplied by publisher]
	A Pilot Feasibility Study of PAL-CHW-PDAC, a Digitally Enhanced Community Health Worker-Led Intervention to Facilitate Stepped Palliative Care in Patients with Pancreatic Cancer. J Palliat Med Thiruvengadam NR, Celestin-Joachim M, Rivas L, Matangi N, Bahmani A, Oroso M, Brothers J, Che K, Chang A, Eguia E, Leonor P, Mohr G, Narayan R, Pathak S, Montgomery S, Ferrell B. PMID: 42681826 [PubMed - as supplied by publisher]
	Advances, challenges, and innovative strategies of CAR-T cell therapy in pancreatic cancer. Biomark Res Xiao RY, Jiang YF, Zhao W, Wang QQ, Huang YQ, Li XY, Xiao YJ, Yao H, Dai RW. PMID: 42681683 [PubMed]
	KRAS signaling networks, mutational heterogeneity, and emerging therapeutic strategies for cancer treatment. Biomark Res Jin S, Zhang Z, Liang F, Yang Y, Lu A, Liang C. PMID: 42681653 [PubMed]
	The Yenos/MinION Multi-Cancer Early Detection Liquid Biopsy Test: An Innovative Approach to MicroRNA Quantification. Methods Mol Biol Kanavarioti A. PMID: 42681330 [PubMed - indexed for MEDLINE]
	The Advanced Lung Cancer Inflammation Index Is Not Independently Prognostic for Overall Survival in De Novo Metastatic Pancreatic Cancer: A Comparison with Established Inflammation- and Nutrition-based Scores. J Gastrointest Cancer Ayd, Köksoy EB. PMID: 42681259 [PubMed - indexed for MEDLINE]
	Danish Pancreatic Cancer Group consensus guidelines on the management of pancreatic IPMN. Acta Radiol Abdolalizadeh B, Fristrup C, Larsen LP, Fallentin E, Ewertsen C. PMID: 42678719 [PubMed - as supplied by publisher]
	Pancreatic ductal adenocarcinomas arising from intraductal papillary mucinous neoplasms are aggressive despite being low stage: implications on screening and "early diagnosis". Virchows Arch Pehlivanoglu B, Muraki T, Reid MD, Memis B, Balci S, Bagci P, Akar KE, Sarmiento J, Kooby D, Maithel SK, Tsai S, Christians K, Evans DB, Adsay V. PMID: 42678419 [PubMed - as supplied by publisher]
	Associations Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Cancer Risk: A Systematic Review and Meta-Analysis. Cancer Control Lalani I, Nambayan R, Carbonell C, Ruan Y, O'Sullivan DE, Stukalin I, Hilsden RJ, Brenner DR. PMID: 42677883 [PubMed - indexed for MEDLINE]
	From dysbiosis to precision oncology: translational role of the microbiome in gastrointestinal cancer. Cell Cycle Adam M, Venugopal A, Almohana A, Awadallah M, Purohit P, Abid A, Jose E, Rajendiran A, Banka P, Ilipilla C, Bhuvan F, Rai M. PMID: 42677508 [PubMed - indexed for MEDLINE]
	Sensitive and Reproducible SERS Profiling of Tumor-Derived EVs via Uniform Microfluidic Nanobowl Arrays for Pancreatic Cancer Management. Nano Lett Wang R, Chen A, Wang Y, Zhao X, Zhang P, Fang X, Yang C. PMID: 42677377 [PubMed - indexed for MEDLINE]
	Bisphenol A and ovarian cancer: emerging evidence and potential biological mechanisms. Front Cell Dev Biol Zhang L, Yu T, Bian Z, Mao T, Xu C. PMID: 42676940 [PubMed]
	Extended versus simple cholecystectomy for pathologic T1b gallbladder cancer: A systematic review and meta-analysis. Ann Hepatobiliary Pancreat Surg Cho IS, Ahn KS, Gwon SH, Son NH, Kim TS, Kim MJ, Kim YH. PMID: 42676070 [PubMed - as supplied by publisher]
	Effectiveness and conversion outcomes of immune checkpoint inhibitors combined with lenvatinib and GEMOX chemotherapy as first-line treatment for advanced gallbladder cancer: A multicenter study. Chin Med J (Engl) Li S, Yu G, Feng S, Piao M, Zhou Z, Li C, Xun Z, Sun B, Li J, Zhang N, Sun Y, Zhu Z, Zhao H. PMID: 42675530 [PubMed - as supplied by publisher]
	Transcriptomic Profiling of Adhesion GPCRs in Pancreatic Adenocarcinoma Identifies ADGRG7 and ADGRF1 as Novel Diagnostic Biomarkers and Therapeutic Targets. Anticancer Res Khan AA, Cho SG. PMID: 42674700 [PubMed - indexed for MEDLINE]
	Neoadjuvant Gemcitabine Plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score-matched Study. Anticancer Res Kishi T, Nakamura K, Tanaka T, Ishitobi K, Kaji S, Taniura T, Matsubara T, Yamamoto T, Hidaka M. PMID: 42674690 [PubMed - indexed for MEDLINE]
	Identification of factors associated with rash during gemcitabine plus nanoparticle albumin-bound paclitaxel treatment for pancreatic cancer. Support Care Cancer Saito Y, Takekuma Y, Komatsu Y, Sugawara M. PMID: 42671618 [PubMed - indexed for MEDLINE]
	Integrated pan-cancer analysis reveals a cancer-associated fibroblast oxidative stress response signature predicting immunotherapy response and prognosis. Apoptosis Tang J, Lv C, Dong S, Song L, Liu Y, Luo D, Long Y, Xiao D, Tao Y, Liu S. PMID: 42671485 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 61363

Seite 1 von 3069

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung